Effects of beta-naphthoflavone administration during midgestation on ovarian steroid metabolism and fetal development.
D000818:Animals; D001571:Benzoflavones / Q000494:pharmacology*; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004967:Estrogens / Q000096:biosynthesis; D005260:Female; D005333:Fetus / Q000187:drug effects* / Q000502:physiology; D005419:Flavonoids / Q000494:pharmacology*; D005865:Gestational Age; D012739:Gonadal Steroid Hormones / Q000096:biosynthesis*; D008861:Microsomes / Q000378:metabolism; D010053:Ovary / Q000187:drug effects* / Q000378:metabolism; D011247:Pregnancy; D011374:Progesterone / Q000096:biosynthesis; D051381:Rats; D013739:Testosterone / Q000096:biosynthesis; D019324:beta-Naphthoflavone
D001571:Benzoflavones; D004967:Estrogens; D005419:Flavonoids; D012739:Gonadal Steroid Hormones; D013739:Testosterone; D011374:Progesterone; D019324:beta-Naphthoflavone; D003577:Cytochrome P-450 Enzyme System